Fintel on MSN12d
JP Morgan Downgrades CARGO Therapeutics (CRGX)
Fintel reports that on January 30, 2025, JP Morgan downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from Overweight to Underweight. Analyst Price Forecast Suggests 146.36% Upside As of ...
Cargo Therapeutics downgraded to Underweight from Overweight at JPMorgan
JPMorgan double downgraded Cargo Therapeutics (CRGX) to Underweight from Overweight without a price target The firm believes the shares will ...
ADVFN12d
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
CARGO Therapeutics, Inc. (NASDAQ ... today announced that the company will participate in the 42nd Annual J.P. Morgan Healthcare Conference, taking place January 8-11, 2024, in San Francisco ...
ADVFN12d
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
CARGO Therapeutics, Inc. (NASDAQ ... today announced that the company will participate in the 43rd Annual J.P. Morgan Healthcare Conference, taking place January 13-16, 2025, in San Francisco ...